Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients

Plastic and Reconstructive Surgery

Volumn 128, Issue 5, 2011, Pages 1093-1103

  Pannucci, Christopher J ^{a,b,c,d,e,f,g,h}   Dreszer, George ^{a,b,c,d,e,f,g}   Wachtman, Christine Fisher ^{a,b,c,d,e,f,g}   Bailey, Steven H ^{a,b,c,d,e,f,g}   Portschy, Pamela R ^{a,b,c,d,e,f,g}   Hamill, Jennifer B ^{a,b,c,d,e,f,g}   Hume, Keith M ^{a,b,c,d,e,f,g}   Hoxworth, Ronald E ^{a,b,c,d,e,f,g}   Rubin, J Peter ^{a,b,c,d,e,f,g}   Kalliainen, Loree K ^{a,b,c,d,e,f,g}   Pusic, Andrea L ^{a,b,c,d,e,f,g}   Wilkins, Edwin G ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF MICHIGAN   (United States)

^b REGIONS HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d University of Texas Southwestern   (United States)

^e JBH Consulting   (United States)

^f American Society of Plastic Surgeons   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h Section of Plastic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN;

ADULT; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PLASTIC SURGERY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIMARY PREVENTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADULT; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SUBCUTANEOUS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURGERY, PLASTIC; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 80155187492     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31822b6817     Document Type: Article

References (53)

1. Kearon C. Natural history of venous thromboembolism. Circulation 2003;107:I22-I30.
2. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008;6:1105-1112.
3. Wakefield TW, McLafferty RB, Lohr JL, et al. Call to action to prevent venous thromboembolism. J Vasc Surg. 2009;49: 1620-1623.
4. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. Available at: Http://www.surgeongeneral.gov/library/calls/ index.html. Accessed March 3, 2011.
5. Seruya M, Venturi ML, Iorio ML, Davison SP. Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients. Plast Reconstr Surg. 2008;122: 1701-1708.
6. Pannucci CJ, Chang EY, Wilkins EG. Venous thromboembolic disease in autogenous breast reconstruction. Ann Plast Surg. 2009;63:34-38.
7. Keyes GR, Singer R, Iverson RE, et al. Mortality in outpatient surgery. Plast Reconstr Surg. 2008;122:245-250; discussion 251-253.
8. Hatef DA, Kenkel JM, Nguyen MQ, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008; 122:269-279.
9. Hume K. ASPS Vice President of Research and Development, personal communication, 2010.
10. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70-78.
11. Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212:105-112.
12. American Society of Plastic Surgeons. (TOPS) Tracking OutcomesandOperations for Plastic Surgeons. Available at: Http://www. plasticsurgery.org/Medical-Professionals/TOPS.html. Accessed March 3, 2011.
13. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251: 344-350.
14. Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010; 199:S3-S10.
15. Liao EC, Taghinia AH, Nguyen LP, Yueh JH, May JW Jr, Orgill DP. Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg. 2008;121:1101-1107.
16. Mismetti P, Laporte S, Darmon JY, Buchmü ller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913-930.
17. Hayward RA, Kent DM, Vijan S, Hofer TP. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol. 2006;6:18.
18. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. Lancet 1999;353:2105-2110.
19. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature: II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1994;271:59-63.
20. Clavijo-Alvarez JA, Pannucci CJ, Oppenheimer AJ, Wilkins EG, Rubin JP. Prevention of venous thromboembolism in body contouring surgery: A national survey of 596 ASPS surgeons. Ann Plast Surg. 2011;66:228-232.
21. Broughton G II, Rios JL, Rohrich RJ, Brown SA. Deep venous thrombosis prophylaxis practice and treatment strategies among plastic surgeons: Survey results. Plast Reconstr Surg. 2007;119:157-174.
22. Pannucci CJ, Oppenheimer AJ, Wilkins EG. Practice patterns in venous thromboembolism prophylaxis: A survey of 606 reconstructive breast surgeons. Ann Plast Surg. 2010;64:732-737.
23. Johnson RL, Hemington-Gorse SJ, Dhital SK. Do cosmetic surgeons consider estrogen-containing drugs to be of significant risk in the development of thromboembolism̂ Aesthetic Plast Surg. 2008;32:743-747.
24. Lembitz A, Clarke TJ. Clarifying "never events" and introducing "always events." Patient Saf Surg. 2009;3:26.
25. Lemaine V, McCarthy C, Kaplan K. Venous thromboembolism following microsurgical breast reconstruction: An objective analysis in 225 consecutive patients using low-molecular- weight heparin prophylaxis. Plast Reconstr Surg. 2011; 127:1399-1406.
26. Murphy RX Jr, Peterson EA, Adkinson JM, Reed JF III. Plastic surgeon compliance with national safety initiatives: Clinical outcomes and "never events." Plast Reconstr Surg. 2010;126: 653-656.
27. Eriksson BI, Dahl OE, Rosencher N, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: A randomised, double- blind, non-inferiority trial. Lancet 2007;370:949-956.
28. Lassen MR, Gallus A, Raskob GE, et al. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363:2487-2498.
29. Lassen MR, Raskob GE, Gallus A, et al. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): A randomised double-blind trial. Lancet 2010;375:807-815.
30. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980.
31. Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: A role for prolonged thromboprophylaxis. Cancer Treat Rev. 2002;28:141-144.
32. Rasmussen MS, Jorgensen LN, Wille-Jørgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: A multicenter randomized open-label study. J Thromb Haemost. 2006;4:2384-2390.
33. Serletti JM. Microvascular free flap failure caused by unrecognized hypercoagulability (Discussion). Plast Reconstr Surg. 2009;124:496-499.
34. Baba-Ahmed M, Le Gal G, Couturaud F, Lacut K, Oger E, Leroyer C. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis. Thromb Haemost. 2007;97:171-175.
35. Davison SP, Kessler CM, Al-Attar A. Microvascular free flap failure caused by unrecognized hypercoagulability. Plast Reconstr Surg. 2009;124:490-495.
36. Friedman T, O'Brien Coon D, Michaels V J, et al. Hereditary coagulopathies: Practical diagnosis and management for the plastic surgeon. Plast Reconstr Surg. 2010;125:1544-1552.
37. Elting LS, Escalante CP, Cooksley C, et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med. 2004;164:1653-1661.
38. Shorr AF, Ramage AS. Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications. Crit Care Med. 2001;29:1659-1665.
39. Schädlich PK, Kentsch M, Weber M, et al. Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: Modelling study from the hospital perspective in Germany. Pharmacoeconomics 2006;24:571-591.
40. Wilbur K, Lynd L, Sadatsafavi M. Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients: A pharmacoeconomic analysis. Clin Appl Thromb Hemost. Epublished ahead of print August 10, 2010.
41. US Food and Drug Administration press release, July 23, 2010. Available at: Http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm220092.htm. Accessed March 3, 2011
42. Miszkiewicz K, Perreault I, Landes G, et al. Venous thromboembolism in plastic surgery: Incidence, current practice and recommendations. J Plast Reconstr Aesthet Surg. 2009;62: 580-588.
43. Venturi ML, Davison SP, Caprini JA. Prevention of venous thromboembolism in the plastic surgery patient: Current guidelines and recommendations. Aesthet Surg J. 2009;29: 421-428.
44. McDevitt NB. Deep vein thrombosis prophylaxis. American Society of Plastic and Reconstructive Surgeons. Plast Reconstr Surg. 1999;104:1923-1928.
45. Davison SP, Venturi ML, Attinger CE, Baker SB, Spear SL. Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg. 2004;114:43E-51E.
46. Young VL, Watson ME. The need for venous thromboembolism (VTE) prophylaxis in plastic surgery. Aesthet Surg J. 2006;26:157-175.
47. Sweetland S, Green J, Liu B, et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: Prospective cohort study. BMJ. 2009; 339:b4583.
48. Kim EK, Eom JS, Ahn SH, Son BH, Lee TJ. The efficacy of prophylactic low-molecular-weight heparin to prevent pulmonary thromboembolism in immediate breast reconstruction using the TRAM flap. Plast Reconstr Surg. 2009;123:9-12.
49. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 2000;117:178-183.
50. Lapidus L, de Bri E, Ponzer S, Elvin A, Norén A, Rosfors S. High sensitivity with color duplex sonography in thrombosis screening after ankle fracture surgery. J Thromb Haemost. 2006;4:807-812.
51. Sugimoto Y, Ito Y, Tomioka M, et al. Deep venous thrombosis in patients with acute cervical spinal cord injury in a Japanese population: Assessment with Doppler ultrasonography. J Orthop Sci. 2009;14:374-376.
52. Wahl WL, Brandt MM, Ahrns K, et al. Venous thrombosis incidence in burn patients: Preliminary results of a prospective study. J Burn Care Rehabil. 2002;23:97-102.
53. Wibbenmeyer LA, Hoballah JJ, Amelon MJ, et al. The prevalence of venous thromboembolism of the lower extremity among thermally injured patients determined by duplex sonography. J Trauma 2003;55:1162-1167.